ADIVO
adivo is a veterinary biotechnology company developing therapeutic antibodies for pets. The focus is on the treatment of serious diseases in dogs with the potential to offer therapies for other species as well. The antibody selection is based on a new, fully synthetic, dog-specific drug library that can be used to isolate antibodies with optimal properties using phage display technology. adivo is a spin-off of MorphoSys AG. Many years of expertise in the development of human therapeutic antibodies transfer the adivo team into veterinary medicine.
ADIVO
Industry:
Biotechnology Therapeutics
Founded:
2012-01-01
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.adivo.vet
Total Employee:
11+
Status:
Active
Contact:
+49 (0) 89 588088-471
Email Addresses:
[email protected]
Total Funding:
2.44 M EUR
Technology used in webpage:
German Server Location
Similar Organizations
VemiCo
VemiCo is a biotechnology company.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - Adivo
European Innovation Council
European Innovation Council investment in Venture Round - Adivo
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Seed Round - Adivo
MorphoSys
MorphoSys investment in Seed Round - Adivo
OCCIDENT
OCCIDENT investment in Seed Round - Adivo
Official Site Inspections
http://www.adivo.vet
- Host name: w82.rzone.de
- IP address: 81.169.145.82
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
More informations about "Adivo"
adivo joins Zoetis to bring the benefits of species-specific antibody ...
“Adding adivo to our R&D organization brings in unique platforms that may accelerate ... For further information, please visit: www.adivo.vet. About Zoetis As the world’s leading animal …See details»
Successful exit for HTGF: adivo joins Zoetis | HTGF
Sep 15, 2023 therapeutics for our beloved furry friends. For further information, please visit: www.adivo.vet. adivo Dr. Kathrin Ladetzki-Baehs Phone +49 89 58 8088 471 E-mail: [email protected]. For media Mario Brkulj Valency …See details»
Adivo GmbH. (9/15/23). "Press Release: Adivo Joins Zoetis to Bring …
“Adding adivo to our R&D organization brings in unique platforms that may accelerate our research and portfolio to potentially help us address our customers’ unmet needs in oncology, …See details»
Successful exit: adivo joins Zoetis - adivo’s team and platform will ...
Sep 19, 2023 adivo and Zoetis have collaborated since 2021 with respect to both canine and feline antibody discovery. In addition to successful research collaborations, adivo’s proprietary …See details»
Veterinary pharmaceuticals company Zoetis buys adivo …
Sep 15, 2023 Zoetis, the global leader in veterinary pharmaceuticals, and adivo have been working together since 2021, now the Puchheim-based company will merge with the U.S. company. In addition to successful research …See details»
adivo launches species-specific feline antibody library FELIXâ„¢ and ...
Jul 14, 2022 For further information, please visit: www.adivo.vet. Contact adivo Dr. Kathrin Ladetzki-Baehs Phone +49 89 58 8088 471 E-mail: [email protected] For media Mario Brkulj …See details»
adivo becomes part of the world’s leading animal health company …
In addition to successful research collaborations, adivo’s proprietary drug development activities led to a promising portfolio of antibody drug candidates in oncology and inflammatory diseases …See details»
Press Release - adivo.vet
Martinsried/ Munich, Germany, February 22, 2021 – adivo GmbH entered into a partnership with a leading animal health company to develop therapeutic antibodies for companion animals. …See details»
A New Era in Animal Health: ADIVO's Momentous …
Sep 20, 2023 Born from the innovative roots of MorphoSys AG in 2018, ADIVO rapidly became a pioneer in veterinary biopharmaceuticals. Their groundbreaking platforms, CEASAR and FELIX, revolutionized the ...See details»
adivo GmbH - now part of Zoetis - LinkedIn
Adivo GmbH - now part of Zoetis Biotechnology Research Puchheim, Bavaria 1,066 followers A pioneer in species-specific therapeutic antibodies for companion animalsSee details»
From passion project to global impact: The story …
Sep 18, 2023 Last Friday, we were able to announce that adivo is now part of Zoetis, a leading multinational veterinary health organization. As one of the founders and CEO of adivo, I am thrilled by this ...See details»
adivo expands global research collaboration with leading animal …
“Today’s news marks the first of potentially several therapeutic partnerships to come for adivo in the feline antibody space. Our team translated all expertise gained with our canine antibody …See details»
Press Release - adivo.vet
Apr 17, 2019 Email: [email protected] Bayer Animal Health GmbH Christine Wunderlich, phone +49 2173 38 5061 Email: [email protected] Forward-Looking Statements …See details»
Zoetis acquires German biotech company adivo - BioPharma Dive
Sep 15, 2023 Boasting a market capitalization of USD 89bn, Zoetis is one of the 100 largest listed companies in the USA. adivo, which spun off from MorphoSys AG in 2018, is a leading …See details»
adivo GmbH • life science startup - HTGF
Aug 20, 2018 adivo is a spin-off from MorphoSys AG, a leading European biopharmaceutical company. The team transfers an in-depth expertise in discovery and development of human …See details»
AdivoVet Company Profile 2024: Valuation, Investors ... - PitchBook
AdivoVet General Information Description. Developer of species-specific therapeutic antibodies intended to meet the medical need of pets. The company creates antibodies for companion …See details»
20221219 adivo LMA Approval
Dec 19, 2022 For further information, please visit: www.adivo.vet. Contact adivo Dr. Kathrin Ladetzki-Baehs Phone +49 89 58 8088 471 E-mail: [email protected] For media Mario Brkulj …See details»
adivo joins Zoetis to bring the benefits of species-specific antibody ...
Sep 15, 2023 “Adding adivo to our R&D organization brings in unique platforms that may accelerate ... www.adivo.vet. About Zoetis . As the world’s leading animal health company, …See details»
Zoetis - Global Animal Health Company | Zoetis
Zoetis and our colleagues are guided by our purpose: to nurture the world and humankind by advancing care for animals. This care is essential to the comfort, companionship and nutrition …See details»
adivo receives EU grant to accelerate development of novel …
For further information, please visit: www.adivo.vet. Contact adivo Dr. Kathrin Ladetzki-Baehs Phone +49 89 58 8088 471 E-mail: [email protected] For media Mario Brkulj Valency …See details»